Telix shares jump 7.2% after new partnership revealed

MELBOURNE: Shares in cancer pharmaceuticals developer Telix jumped as much as 7.2 per ...

To read the full story...SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In